George E. MacDougall

Head of Investor Relations @ REGENXBIO Inc. (Nasdaq: RGNX) | MBA, Strategic Communicator

📍 United States🔄 Updated September 2026💼 2 investments📅 17 years investing🗓 Last invested Aug 2024
Angel investor🌍 United States
2
Total investments
0
Early stage
0
Mid stage
0
Late stage
17y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Aug 2024
The Boston Chapter of the National Investor Relations Institute (NIRI Boston) is dedicated to the professional advancement of its members by supporting the Investor Relations function. NIRI Boston is committed to fostering a greater understanding of effective and ethical investor relations practices.
Experience · 2 entries
All (2)
Investments (2)
Board (1)
2024
Board Member
Aug 2024
The Boston Chapter of the National Investor Relations Institute (NIRI Boston) is dedicated to the professional advancement of its members by supporting the Investor Relations function. NIRI Boston is committed to fostering a greater understanding of effective and ethical investor relations practices.
2009
Coordinator, Partnering & Investor Programs
Aug 2009
BIO is the premier biotechnology advocacy organization representing biotech companies, industry leaders, and state biotech associations in the United States and more than 35 countries around the globe. BIO members range from biotech start-ups to some of the world’s largest biopharmaceutical companies – all united by the same goal: to develop medical and scientific breakthroughs that prevent and fight disease, restore health, and improve patients’ lives. BIO also organizes the BIO International Convention and a series of annual conferences that drive partnerships, investment, and progress within the sector. Learn more at bio.org